Cited by 212Cancer Cells and MetastasisMesenchymal stem cell researchDevelopmental Biology and Gene Regulation

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Mammosphere Formation in Breast Carcinoma Cell Lines Depends upon Expression of E-cadherin

Open access
Manuel Iglesias, Juan, Beloqui, Izaskun, Garcia-Garcia, Francisco, Leis, Olatz, Vazquez-Martin, Alejandro, Eguiara, Arrate, Cufi, Silvia, Pavon, Andres, Menendez, Javier A., Dopazo, Joaquin, Martin, Angel G.·2013·PLoS ONE

Abstract

Tumors are heterogeneous at the cellular level where the ability to maintain tumor growth resides in discrete cell populations. Floating sphere-forming assays are broadly used to test stem cell activity in tissues, tumors and cell lines. Spheroids are originated from a small population of cells with stem cell features able to grow in suspension culture and behaving as tumorigenic in mice. We tested the ability of eleven common breast cancer cell lines representing the major breast cancer subtypes to grow as mammospheres, measuring the ability to maintain cell viability upon serial non-adherent passage. Only MCF7, T47D, BT474, MDA-MB-436 and JIMT1 were successfully propagated as long-term mammosphere cultures, measured as the increase in the number of viable cells upon serial non-adherent passages. Other cell lines tested (SKBR3, MDA-MB-231, MDA-MB-468 and MDA-MB-435) formed cell clumps that can be disaggregated mechanically, but cell viability drops dramatically on their second passage. HCC1937 and HCC1569 cells formed typical mammospheres, although they could not be propagated as long-term mammosphere cultures. All the sphere forming lines but MDA-MB-436 express E-cadherin on their surface. Knock down of E-cadherin expression in MCF-7 cells abrogated its ability to grow as mammospheres, while re-expression of E-cadherin in SKBR3 cells allow them to form mammospheres. Therefore, the mammosphere assay is suitable to reveal stem like features in breast cancer cell lines that express E-cadherin.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0077281

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Breast cancer cell lines characteristics in suspension culture. A) Breast cancer cell lines included in the study showing their origin and main molecular characteristics (IDC, invasive ductal carcinoma; AC, adenocarcinoma; DC, ductal carcinoma; P, primary tumor; M, metastasis; black box, positive; white box, boxes color code stated in the figure). B) Proliferation of breast cancer cell lines in suspension culture. Cell proliferation was measured as the increase in the number of viable cells upon serial non-adherent passages. C) Morphology of the human breast cancer cell lines included in the study. The morphology of the cell lines growing in adhesion is shown in the top row, indicated as T0. Subsequent passages in suspension culture are termed Tn, where n represents the passage number (Magnification 120X).
Figure 1 Breast cancer cell lines characteristics in suspension culture. A) Breast cancer cell lines included in the study showing their origin and main molecular characteristics (IDC, invasive ductal carcinoma; AC, adenocarcinoma; DC, ductal carcinoma; P, primary tumor; M, metastasis; black box, positive; white box, boxes color code stated in the figure). B) Proliferation of breast cancer cell lines in suspension culture. Cell proliferation was measured as the increase in the number of viable cells upon serial non-adherent passages. C) Morphology of the human breast cancer cell lines included in the study. The morphology of the cell lines growing in adhesion is shown in the top row, indicated as T0. Subsequent passages in suspension culture are termed Tn, where n represents the passage number (Magnification 120X).CC BY · PubMed Central
Figure 2 Gene expression profiling of the breast cancer cell lines included in the study. Left panel: clustering of the genes differentially expressed (p-value < 0.001) between the 3 groups of cell lines identified based on their proliferation and morphological characteristics in suspension culture. Blue squares represent transcript levels below the median; white squares represent transcript levels equal to the median; red squares represent transcript levels greater than the median. Right panel: functional annotation of biological processes overrepresented among the genes differentially expressed between the three groups of cell lines.
Figure 2 Gene expression profiling of the breast cancer cell lines included in the study. Left panel: clustering of the genes differentially expressed (p-value < 0.001) between the 3 groups of cell lines identified based on their proliferation and morphological characteristics in suspension culture. Blue squares represent transcript levels below the median; white squares represent transcript levels equal to the median; red squares represent transcript levels greater than the median. Right panel: functional annotation of biological processes overrepresented among the genes differentially expressed between the three groups of cell lines.CC BY · PubMed Central
Figure 3 E-cadherin expression in LTSF (A), STSF (B) and NSF (C) breast cancer cell lines growing in adhesion and suspension culture assessed by immunofluorescence.
Figure 3 E-cadherin expression in LTSF (A), STSF (B) and NSF (C) breast cancer cell lines growing in adhesion and suspension culture assessed by immunofluorescence.CC BY · PubMed Central
Figure 4 E-cadherin knock-down in MCF7 cells inhibits mammosphere formation. A) Immunofluorescence staining of MCF7 shE-cad and control cells to show the knockdown of E-cadherin expression. B) Morphology of MCF7 shE-cad and control cells growing in adhesion and suspension culture. C) Proliferation of MCF7 shE-cad and control cells in suspension culture. Proliferation was measured as the increase in the number of viable cells upon serial non-adherent passages. The plot was made using data from 3 independent experiments. N.O.=Non observed.
Figure 4 E-cadherin knock-down in MCF7 cells inhibits mammosphere formation. A) Immunofluorescence staining of MCF7 shE-cad and control cells to show the knockdown of E-cadherin expression. B) Morphology of MCF7 shE-cad and control cells growing in adhesion and suspension culture. C) Proliferation of MCF7 shE-cad and control cells in suspension culture. Proliferation was measured as the increase in the number of viable cells upon serial non-adherent passages. The plot was made using data from 3 independent experiments. N.O.=Non observed.CC BY · PubMed Central
Figure 5 Expression of E-cadherin in SKBR3 cells induces sphere formation. A) Immunofluorescence staining of SKBR3 E-cadherin and WT cells showing the expression of E-cadherin. B) Morphology of SKBR3 E-cadherin and WT cells growing in adhesion and suspension culture. C) Quantitation of the number of spheres made by SKBR3 E-cadherin and WT cells in T0. The plot was made using data from 3 independent experiments.
Figure 5 Expression of E-cadherin in SKBR3 cells induces sphere formation. A) Immunofluorescence staining of SKBR3 E-cadherin and WT cells showing the expression of E-cadherin. B) Morphology of SKBR3 E-cadherin and WT cells growing in adhesion and suspension culture. C) Quantitation of the number of spheres made by SKBR3 E-cadherin and WT cells in T0. The plot was made using data from 3 independent experiments.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 45

  1. JE Visvader, 2008, Cancer stem cells in solid tumours: accumulating evidence and unresolved questions, Nat Rev Cancer, 8, 755, 10.1038/nrc2499 · DOI
  2. CA O’Brien, 2009, Cancer stem cells in solid tumors: an overview, Semin Radiat Oncol, 19, 71, 10.1016/j.semradonc.2008.11.001 · DOI
  3. M Al-Hajj, 2003, Prospective identification of tumorigenic breast cancer cells, Proc Natl Acad Sci U S A, 100, 3983, 10.1073/pnas.0530291100 · DOI
  4. E Mylona, 2008, The clinicopathologic and prognostic significance of CD44+/CD24(-/low) and CD44-/CD24+ tumor cells in invasive breast carcinomas, Hum Pathol, 39, 1096, 10.1016/j.humpath.2007.12.003 · DOI
  5. G Honeth, 2008, The CD44+/CD24- phenotype is enriched in basal-like breast tumors, Breast Cancer Res BCR, 10, R53, 10.1186/bcr2108 · DOI
  6. CT Jordan, 2009, Cancer stem cells: controversial or just misunderstood?, Cell Stem Cell, 4, 203, 10.1016/j.stem.2009.02.003 · DOI
  7. G Dontu, 2003, In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells, Genes Dev, 17, 1253, 10.1101/gad.1061803 · DOI
  8. BA Reynolds, 1992, Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system, Science (New York, NY), 255, 1707, 10.1126/science.1553558 · DOI · Paper page
  9. E Diaz-Guerra, 2012, Intrinsic cues and hormones control mouse mammary epithelial tree size, FASEB J, 26, 3844, 10.1096/fj.11-200782 · DOI
  10. M Serrano, 2000, The INK4a/ARF locus in murine tumorigenesis, Carcinogenesis, 21, 865, 10.1093/carcin/21.5.865 · DOI
  11. D Dey, 2009, Phenotypic and functional characterization of human mammary stem/progenitor cells in long term culture, PLOS ONE, 4, e5329, 10.1371/journal.pone.0005329 · DOI
  12. A Cicalese, 2009, The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells, Cell, 138, 1083, 10.1016/j.cell.2009.06.048 · DOI
  13. D Ponti, 2005, Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties, Cancer Res, 65, 5506, 10.1158/0008-5472.CAN-05-0626 · DOI
  14. MJ Grimshaw, 2008, Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells, Breast Cancer Res BCR, 10, R52, 10.1186/bcr2106 · DOI
  15. M Cioce, 2010, Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs, Cell Cycle (Georgetown, Tex), 9, 2878, 10.4161/cc.9.14.12371 · DOI
  16. SA Mani, 2008, The epithelial-mesenchymal transition generates cells with properties of stem cells, Cell, 133, 704, 10.1016/j.cell.2008.03.027 · DOI
  17. S Borgna, 2012, Mesenchymal traits are selected along with stem features in breast cancer cells grown as mammospheres, Cell Cycle (Georgetown, Tex), 11, 4242, 10.4161/cc.22543 · DOI
  18. C Oliveras-Ferraros, 2012, Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin), Cell Cycle (Georgetown, Tex), 11, 4020, 10.4161/cc.22225 · DOI
  19. O Leis, 2012, Sox2 expression in breast tumours and activation in breast cancer stem cells, Oncogene, 31, 1354, 10.1038/onc.2011.338 · DOI
  20. BM Bolstad, 2003, A comparison of normalization methods for high density oligonucleotide array data based on variance and bias, Bioinformatics (Oxf, England), 19, 185, 10.1093/bioinformatics/19.2.185 · DOI
  21. Y Benjamini, 1995, Controlling the false discovery rate: a practical and powerful approach to multiple testing, J R Stat Soc B Stat Methodol, 57, 289, 10.1111/j.2517-6161.1995.tb02031.x · DOI · Paper page
  22. F Al-Shahrour, 2007, From genes to functional classes in the study of biological systems, BMC Bioinformatics, 8, 114, 10.1186/1471-2105-8-114 · DOI
  23. I Medina, 2010, Babelomics: an integrative platform for the analysis of transcriptomics, proteomics and genomic data with advanced functional profiling, Nucleic Acids Res, 38, W210, 10.1093/nar/gkq388 · DOI
  24. Y Benjamini, 2001, The control of the false discovery rate in multiple testing under dependency, Ann Statist, 29, 1165, 10.1214/aos/1013699998 · DOI · Paper page
  25. S Götz, 2008, High-throughput functional annotation and data mining with the Blast2GO suite, Nucleic Acids Res, 36, 3420, 10.1093/nar/gkn176 · DOI
  26. TT Onder, 2008, Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways, Cancer Res, 68, 3645, 10.1158/0008-5472.CAN-07-2938 · DOI
  27. BLK Coles-Takabe, 2008, Don’t look: growing clonal versus nonclonal neural stem cell colonies, Stem Cells (Dayton, Ohio), 26, 2938, 10.1634/stemcells.2008-0558 · DOI
  28. O Leis, 2011, Sox2 expression in breast tumours and activation in breast cancer stem cells, Oncogene, 31, 1354, 10.1038/onc.2011.338 · DOI
  29. RM Neve, 2006, A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes, Cancer Cell, 10, 515, 10.1016/j.ccr.2006.10.008 · DOI
  30. F Elstrodt, 2006, BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants, Cancer Res, 66, 41, 10.1158/0008-5472.CAN-05-2853 · DOI
  31. DT Ross, 2000, Systematic variation in gene expression patterns in human cancer cell lines, Nat Genet, 24, 227, 10.1038/73432 · DOI · Paper page
  32. RC Gentleman, 2004, Bioconductor: open software development for computational biology and bioinformatics, Genome Biol, 5, R80, 10.1186/gb-2004-5-10-r80 · DOI
  33. S Hiraguri, 1998, Mechanisms of inactivation of E-cadherin in breast cancer cell lines, Cancer Res, 58, 1972
  34. CM Fillmore, 2008, Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy, Breast Cancer Res, 10, R25, 10.1186/bcr1982 · DOI
  35. C Lehmann, 2012, Established breast cancer stem cell markers do not correlate with in vivo tumorigenicity of tumor-initiating cells, Int J Oncol, 41, 1932, 10.3892/ijo.2012.1654 · DOI
  36. D Sarrio, 2012, Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties, Stem Cells (Dayton, Ohio), 30, 292, 10.1002/stem.791 · DOI
  37. D Sarrio, 2012, Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties, Stem Cells, 30, 292, 10.1002/stem.791 · DOI
  38. PJ Keller, 2010, Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines, Breast Cancer Res BCR, 12, R87, 10.1186/bcr2755 · DOI
  39. S Ricardo, 2011, Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype, J Clin Pathol, 51, 1659
  40. FL Shaw, 2012, A detailed mammosphere assay protocol for the quantification of breast stem cell activity, J Mammary Gland Biol Neoplasia, 17, 111, 10.1007/s10911-012-9255-3 · DOI
  41. L Piggott, 2011, Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL, Breast Cancer Res BCR, 13, R88, 10.1186/bcr2945 · DOI
  42. E Pastrana, 2011, Eyes wide open: a critical review of sphere-formation as an assay for stem cells, Cell Stem Cell, 8, 486, 10.1016/j.stem.2011.04.007 · DOI
  43. PL Ryan, 2001, Tissue spreading on implantable substrates is a competitive outcome of cell-cell vs. cell-substratum adhesivity, Proc Natl Acad Sci U S A, 98, 4323, 10.1073/pnas.071615398 · DOI
  44. D Duguay, 2003, Cadherin-mediated cell adhesion and tissue segregation: qualitative and quantitative determinants, Dev Biol, 253, 309, 10.1016/S0012-1606(02)00016-7 · DOI
  45. T Celià-Terrassa, 2012, Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells, J Clin Invest, 122, 1849, 10.1172/JCI59218 · DOI

Cited by

Sorted by citations

See all 212

Metadata

Authors
Manuel Iglesias, J., Beloqui, I., Garcia-Garcia, F., Leis, O., Vazquez-Martin, A., Eguiara, A., Cufi, S., Pavon, A., Menendez, J. A., Dopazo, J., & Martin, A. G.
Venue
PLoS ONE
Published
2013-10-04
Volume
8
Issue
10
Pages
e77281
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2025690227
Cited by
212
References
1
Citations by year
2026: 7 · 2025: 10 · 2024: 12 · 2023: 17 · 2022: 12 · 2021: 21 · 2020: 11 · 2019: 26 · 2018: 29 · 2017: 23 · 2016: 17 · 2015: 16 · 2014: 9 · 2013: 2
FWCI
7.86
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
Funders
  • Eusko Jaurlaritza
  • Generalitat Valenciana
  • Ministerio de Ciencia e Innovación (BIO2011-27069)
  • Instituto de Salud Carlos III (CD08/00283)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
Keywords
mammosphere formation, breast cancer cell lines, E-cadherin, cancer stem cells, tumor heterogeneity, MCF-7 cells, SKBR3, breast cancer subtypes
MeSH terms
Breast Neoplasms, Female, Humans, Tumor Cells, Cultured, Neoplastic Stem Cells, Cadherins, Gene Expression, Gene Expression Regulation, Neoplastic, Cluster Analysis, Spheroids, Cellular, Gene Expression Profiling, Cell Line, Tumor, Cell Proliferation, Gene Knockdown Techniques, MCF-7 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review